Original article
NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma
Gustavo Nery de Queiroza, Keli Limaa,b, Livia Bassani Lins de Mirandaa, Eduardo Magalhães Regob,c, Fabiola Trainac,d, João Agostinho Machado-Netoa,
Corresponding author
jamachadoneto@usp.br
Corresponding author at: Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524, CEP 05508-900, São Paulo, SP, Brazil.
Corresponding author at: Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524, CEP 05508-900, São Paulo, SP, Brazil.
a Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
b Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Hematology Division, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil
c Center for Cell Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil
d Department of Medical Imaging, Hematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil
Read
1322
Timeswas read the article
368
Total PDF
954
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 April | 62 | 17 | 79 |
| 2025 March | 81 | 16 | 97 |
| 2025 February | 53 | 23 | 76 |
| 2025 January | 39 | 15 | 54 |
| 2024 December | 38 | 27 | 65 |
| 2024 November | 66 | 22 | 88 |
| 2024 October | 50 | 21 | 71 |
| 2024 September | 90 | 24 | 114 |
| 2024 August | 81 | 32 | 113 |
| 2024 July | 86 | 62 | 148 |
| 2024 June | 94 | 27 | 121 |
| 2024 May | 79 | 35 | 114 |
| 2024 April | 94 | 18 | 112 |
| 2024 March | 41 | 29 | 70 |
Show all
